Vitamin D status and supplementation in left ventricular remodeling in chronic kidney disease: A systematic review and meta-analysis.

TL;DR

Higher Vitamin D levels correlate with less heart thickening in chronic kidney disease, but supplementation studies don't yet prove vitamin D pills improve cardiac structure. observational evidence exists for the association; evidence for supplementation effects.

What the Study Found

Chronic kidney disease (CKD) creates a cascade of problems for the heart. As kidney function declines, the heart's left ventricle thickens and remodels in ways that increase cardiovascular risk and mortality. Vitamin D deficiency is rampant in this population, raising the question: could restoring vitamin D status protect cardiac structure? A new systematic review and meta-analysis examined 16 studies involving over 2,000 people to answer this question.

The observational data showed a relationship worth noting. In studies measuring vitamin D levels and heart structure, higher vitamin D correlated with lower left ventricular mass index (LVMI), a key measure of heart thickening. The correlation coefficient was -0.41, suggesting a moderate negative association: more vitamin D corresponded with less cardiac remodeling. However, this finding came with significant caveats. Heterogeneity between studies was substantial, and the certainty of evidence was rated very low. Different studies used different vitamin D cutoffs, different populations, and different cardiac measurement techniques, making firm conclusions difficult.

The interventional studies painted a different picture. When researchers actually gave people vitamin D supplements and measured cardiac outcomes, the results were disappointing. Nine randomized trials involving 581 participants found that vitamin D supplementation did not significantly reduce left ventricular mass index compared to placebo or control conditions. There was also no improvement in left ventricular ejection fraction (LVEF), a measure of how effectively the heart pumps blood. A possible reduction in interventricular septal thickness (IVST), the wall between the heart's ventricles, was observed, but this was based on limited data with inconsistent results across trials.

The authors were clear about what this means: association is not causation. The fact that observational studies found lower vitamin D linked to worse heart remodeling doesn't prove that vitamin D deficiency causes the problem or that supplementation fixes it. The interventional evidence, which directly tests whether giving vitamin D helps, currently doesn't support a benefit for cardiac structure in CKD populations. The authors called for larger, longer, better-designed trials to determine whether specific subgroups of CKD patients might still benefit.

What This Means for You

If you have chronic kidney disease and vitamin D deficiency, this research doesn't argue against correcting low vitamin D levels. Vitamin D plays multiple roles in bone health, immune function, and other processes independent of heart structure. The finding here is narrower: we don't yet have solid evidence that vitamin D supplementation reshapes the thickened hearts of people with CKD.

The discrepancy between observational and interventional evidence is instructive. Observational associations often reflect complex confounding rather than true causal relationships. People with higher vitamin D may differ from those with lower vitamin D in multiple unmeasured ways: sun exposure patterns, diet quality, physical activity, medication adherence, and disease severity all differ and all affect heart health. Intervention trials isolate the supplement's effect, and so far they show vitamin D alone doesn't reliably improve LVMI or ejection fraction.

For CKD patients, the research priorities should be clear: managing blood pressure, controlling proteinuria, optimizing kidney function, and managing mineral metabolism remain the proven levers for cardiac protection. If vitamin D is low, correcting it makes sense for other health reasons. But banking on supplementation to reverse cardiac remodeling is not yet justified by the evidence.

Study Details

Sources

Vitamin D status and supplementation in left ventricular remodeling in chronic kidney disease: A systematic review and meta-analysis. *Biomolecules & Biomedicine*. PubMed: 42572961